You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 4,775,529


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,775,529
Title: Steroid lotion
Abstract:An improved lotion formulation for the topical administration of corticosteroids in a hydro-alcoholic base containing propylene glycol.
Inventor(s): Sequeira; Joel A. (New York, NY), Munayyer; Farah J. (West Caldwell, NJ), Galeos; Rebecca (Bloomfield, NJ)
Assignee: Schering Corporation (Kenilworth, NJ)
Application Number:07/053,172
Patent Claim Types:
see list of patent claims
Use; Compound; Composition; Formulation;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 4,775,529

To conduct a detailed analysis of the scope and claims of United States Patent 4,775,529, it is essential to delve into several key aspects of patent law, the patent itself, and the broader patent landscape.

Patent Basics

Before diving into the specifics of the patent, it's crucial to understand some basic concepts of patent law.

What is a Patent?

A patent is a form of intellectual property that gives the patent holder the exclusive right to make, use, and sell an invention for a specified period, typically 20 years from the filing date of the patent application[1].

Types of Patents

There are several types of patents, including utility patents, design patents, and plant patents. Utility patents, which are the most common, cover functional inventions and are likely the category under which U.S. Patent 4,775,529 falls.

Patent 4,775,529 Overview

Invention Description

To analyze the scope and claims of U.S. Patent 4,775,529, one must first understand what the patent describes. This involves reading the patent's abstract, detailed description, and claims. The abstract provides a brief summary of the invention, while the detailed description explains how the invention works and its various components. The claims define the scope of the invention and what is protected by the patent.

Claims Analysis

The claims section is critical as it outlines the specific elements of the invention that are protected. Each claim must be clear, concise, and fully supported by the description. There are independent claims and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[1].

Subject Matter Eligibility

Section 101 of the Patent Act

Under U.S. patent law, Section 101 of the Patent Act determines what subject matter is eligible for patent protection. The patent must fall within one of the four statutory categories: processes, machines, manufactures, or compositions of matter. Additionally, it must not be directed to abstract ideas, natural phenomena, or laws of nature without an inventive concept that transforms the abstract idea into a patent-eligible invention[1].

Alice Test

The Alice test, established by the Supreme Court in the case of Alice Corp. v. CLS Bank International, is a two-step process to determine if a patent claim is directed to an abstract idea. Step one involves determining whether the claim is directed to an abstract idea, and step two involves assessing whether the claim contains an inventive concept that transforms the abstract idea into a patent-eligible invention[1].

Patent Prosecution and Challenges

Patent Trial and Appeal Board (PTAB)

The PTAB, established by the Leahy-Smith America Invents Act (AIA), provides a forum for challenging the validity of issued patents through inter partes review (IPR) and post-grant review (PGR). These procedures are often faster and less expensive than federal court litigation and require a lower standard of proof to invalidate patents[2].

Inter Partes Review (IPR) and Post-Grant Review (PGR)

IPR and PGR allow parties to challenge the validity of patents before the PTAB. These challenges can be initiated by anyone, regardless of whether they have been sued or threatened with a patent lawsuit. The process typically takes less than a year and involves a panel of administrative patent judges (APJs)[2].

Patent Allowance Rates and Continuations

Patent Allowance Rates

The probability of receiving a U.S. patent can be measured in several ways, including first-action allowance rates, progenitor allowance rates, and family allowance rates. These rates help in understanding the likelihood of a patent application being granted and the complexity of the examination process[4].

Continuations and RCEs

Continuations, such as Request for Continued Examination (RCE), allow applicants to continue the prosecution of their patent applications. These can complicate the calculation of allowance rates but are crucial for understanding the full scope of a patent family[4].

Economic and Statistical Context

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents granted between 1976 and 2014. This dataset can be used to analyze trends in patent scope and the characteristics of patent claims over time[3].

Case Law and Judicial Precedents

Recent Court Decisions

Recent court decisions, such as AI Visualize, Inc. v. Nuance Communications, Inc., highlight the ongoing challenges in determining patent eligibility under Section 101. These cases often involve complex analyses of whether the claims are directed to abstract ideas and whether they contain an inventive concept[5].

Key Takeaways

  • Patent Scope and Claims: The scope of a patent is defined by its claims, which must be clear, concise, and supported by the detailed description.
  • Subject Matter Eligibility: Patents must fall within the statutory categories and not be directed to abstract ideas without an inventive concept.
  • PTAB and Administrative Challenges: IPR and PGR provide efficient means to challenge patent validity, often preferred over federal court litigation.
  • Allowance Rates and Continuations: Understanding allowance rates and continuation procedures is crucial for navigating the patent examination process.
  • Economic and Statistical Context: Datasets and economic research help in analyzing trends and characteristics of patent claims.

FAQs

What is the purpose of the PTAB?

The PTAB was created to improve patent quality by providing a more efficient system for challenging patents that should not have issued, thereby reducing litigation by "patent trolls"[2].

How does the Alice test determine patent eligibility?

The Alice test involves two steps: determining if the claim is directed to an abstract idea, and assessing if the claim contains an inventive concept that transforms the abstract idea into a patent-eligible invention[1].

What are continuations in patent applications?

Continuations, such as RCEs, allow applicants to continue the prosecution of their patent applications, which can complicate the calculation of allowance rates but are essential for patent strategy[4].

How do IPR and PGR differ from federal court litigation?

IPR and PGR are faster, less expensive, and require a lower standard of proof compared to federal court litigation. They also do not require standing, allowing anyone to challenge a patent[2].

What is the significance of the Patent Claims Research Dataset?

The dataset provides detailed information on claims from U.S. patents, enabling the analysis of trends in patent scope and claim characteristics over time[3].

Sources

  1. BitLaw: Patent Law in the United States - BitLaw.
  2. Congressional Research Service: The Patent Trial and Appeal Board and Inter Partes Review.
  3. USPTO: Patent Claims Research Dataset.
  4. Yale Journal of Law and Technology: What Is the Probability of Receiving a US Patent?
  5. CAFC: AI VISUALIZE, INC. v. NUANCE COMMUNICATIONS, INC.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 4,775,529

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.